Prot# EIDOS-AG10-202: An Open-Label Extension and Safety Monitoring Study of Patients with Symptomatic Transthyretin Cardiomyopathy Who Have Completed the Phase II Study AG10-201

Project: Research project

Project Details

StatusActive
Effective start/end date5/8/185/8/21

Funding

  • Eidos Therapeutics, Inc. (EIDOS AG10-202)